China: Pharmaron acquires US API manufacturing site from Noramco

Hong Kong and Shenzhen-listed, Pharmaron Beijing, and R&D and CRO service provider for the life sciences industry, has entered into a definitive agreement to acquire the Coventry active pharmaceutical ingredient (API) manufacturing site in the US from Noramco. The acquisition expands Pharmaron’s chemistry and manufacturing global services into the US. The Coventry Site in Rhode Island…

You must be a HMI Subscriber to view this content.

Subscribe Now »